Anus Neoplasms: Clinical Trials

294 trials for Anus Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

131 completed, 52 recruiting, 38 unknown, 26 terminated. 79 Phase 2, 68 Phase 1, 58 Not applicable, 25 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 279Completed 30, Recruiting 12, Active not recruiting 11, Unknown 10, Terminated 8, Not yet recruiting 4, Withdrawn 3, Enrolling by invitation 1
Phase 168Completed 41, Terminated 9, Recruiting 8, Active not recruiting 4, Not yet recruiting 3, Unknown 3
Not applicable58Completed 24, Recruiting 17, Unknown 8, Not yet recruiting 6, Terminated 2, Active not recruiting 1
Phase 325Completed 13, Active not recruiting 6, Unknown 3, Recruiting 2, Terminated 1
Phase 42Unknown 2

Follow Anus Neoplasms: new trials by email Literature Review of Anus Neoplasms trials Research Report on Anus Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer
Phase 1 / Phase 2Not yet recruitingUniversity of Nebraska2002026-12-012026-10-08
Swabs in Screening for HPV (SWISH)
Self-collected anal swab - Anal Cancer, Human Papilloma Virus (HPV)
Not applicableNot yet recruitingKirby Institute7002026-11-012026-08-27
Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of Immunosuppression
Anal Self-Sampling for High-Risk HPV Detection - Human Papillomavirus Infection, Anal HPV Infection
Not applicableNot yet recruitingUniversity Hospital, Montpellier1902026-10-012026-10-05
Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors
Mind-Body Group Intervention, Enhanced Usual Care Control (EUCC) - Colorectal Cancer (Diagnosis), Anal Cancer
Not applicableNot yet recruitingMassachusetts General Hospital1002026-10-012026-09-08
Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
Lenvatinib, Pembrolizumab - Anal Squamous Cell Carcinoma
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center172026-09-302026-07-02
Blood Biomarkers Based Screening for HPV-driven OPC
HPV16-E6 serology and HPV ctDNA - Head and Neck Squamous Cell Carcinoma, Anal Cancer
Not applicableNot yet recruitingUNICANCER100002026-09-012026-05-26
Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell Carcinoma
Hypofractionated Radiation Therapy - Anal Cancer
Phase 2Enrolling by invitationUniversity of Vermont Medical Center242026-08-262026-09-15
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
IDP-001 - Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1 / Phase 2RecruitingInduPro, Inc.1322026-07-082026-09-03
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
HIV (Human Immunodeficiency Virus), AIDS
Not yet recruitingShenzhen Third People's Hospital10002026-07-012026-07-10
ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
HPV ctDNA Response based radiation, Chemotherapy, Retifanlimab - Anal Cancer, HPV-Related Carcinoma
Phase 2RecruitingJennifer Dorth332026-06-192026-08-14
CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
PDS0101 - HPV Associated Cancers, HIV (Human Immunodeficiency Virus)
Phase 2WithdrawnUniversity of California, San Diego2026-04-302026-08-19
Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study
Assessment of sexual quality of life - Pelvic Cancer, Anal Cancer
Not applicableNot yet recruitingInstitut du Cancer de Montpellier - Val d'Aurelle422026-04-022026-04-13
Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma
Intensity-Modulated Radiotherapy (IMRT), Capecitabine, Sintilimab - Anal Squamous Cell Carcinoma, Limited-stage
Phase 3RecruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences3502026-03-172026-07-09
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Biospecimen Collection, Prasterone, Survey Administration - Anal Carcinoma, Cervical Carcinoma
Phase 2RecruitingOhio State University Comprehensive Cancer Center252026-03-122026-04-21
Distance-Based Exercise to Preserve Function and Prevent Disability
Exercise intervention, Telemedicine, Aerobic Exercise Intervention - Localized Malignant Solid Neoplasm, Anal Cancer
Not applicableRecruitingAlliance for Clinical Trials in Oncology1042026-02-112026-10-02
Self-sampling to Optimize Anal Lesion Outcomes
Self-sampling, Nylon-flocked Swab - Anal Cancer
Not applicableRecruitingMedical College of Wisconsin5722025-11-182026-05-12
Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer
Anal Cancer
RecruitingAarhus University Hospital802025-11-132025-12-22
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
EVOLVE104 - Bladder Cancer, Squamous Cell Carcinoma of the Lung
Phase 1RecruitingEvolveImmune United, Inc1602025-11-132026-09-15
Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment
Electronic Health Record Review, Fluoroscopy, Ganglion Impar Neurolysis - Localized Anal Carcinoma, Localized Anal Margin Carcinoma
Not applicableRecruitingEmory University52025-11-102026-01-30

Showing 20 of 294. Sign in to see all of them.

Narrower conditions

Uterine Cervical Neoplasms (86)  ·  Rectal Neoplasms (57)  ·  Stomach Neoplasms (52)  ·  Pancreatic Neoplasms (47)  ·  Esophageal Neoplasms (46)  ·  Vulvar Neoplasms (46)  ·  Colonic Neoplasms (45)  ·  Penile Neoplasms (40)  ·  Breast Neoplasms (36)  ·  Neoplasms (36)  ·  Squamous Cell Carcinoma of Head and Neck (34)  ·  Vaginal Neoplasms (33)  ·  Prostatic Neoplasms (32)  ·  Urinary Bladder Neoplasms (32)

Broader conditions

Digestive System Diseases (294)  ·  Digestive System Neoplasms (294)  ·  Gastrointestinal Diseases (294)  ·  Intestinal Diseases (294)  ·  Neoplasms by Site (294)  ·  Rectal Diseases (294)  ·  Anus Diseases (293)  ·  Intestinal Neoplasms (293)  ·  Gastrointestinal Neoplasms (287)  ·  Colorectal Neoplasms (264)  ·  Neoplasms (258)  ·  Rectal Neoplasms (237)  ·  Urogenital Diseases (147)  ·  Genital Diseases (141)  ·  Urogenital Neoplasms (109)

Interventions

Fluorouracil (26)  ·  Mitomycin (18)  ·  Radiotherapy (18)  ·  Capecitabine (13)  ·  Cisplatin (12)  ·  pembrolizumab (11)  ·  Cyclophosphamide (9)  ·  Magnetic Resonance Spectroscopy (9)  ·  Biopsy (8)  ·  Paclitaxel (8)  ·  Radiation (8)  ·  Carboplatin (7)  ·  Drug Therapy (7)  ·  Nivolumab (7)  ·  Specimen Handling (7)

Sponsors

National Cancer Institute (NCI) (22)  ·  AIDS Malignancy Consortium (11)  ·  M.D. Anderson Cancer Center (8)  ·  Stanford University (6)  ·  University Health Network, Toronto (5)  ·  Aarhus University Hospital (4)  ·  Medical College of Wisconsin (4)  ·  Memorial Sloan Kettering Cancer Center (4)  ·  Sahlgrenska University Hospital (4)  ·  UNICANCER (4)  ·  Alliance for Clinical Trials in Oncology (3)  ·  Beijing Health Guard Biotechnology, Inc (3)  ·  ECOG-ACRIN Cancer Research Group (3)  ·  Incyte Corporation (3)  ·  Jonsson Comprehensive Cancer Center (3)

Countries

United States (160)  ·  France (26)  ·  China (17)  ·  Canada (15)  ·  United Kingdom (14)  ·  Australia (12)  ·  Denmark (12)  ·  Sweden (11)  ·  Germany (10)  ·  Spain (10)  ·  Italy (9)  ·  Belgium (7)  ·  Brazil (6)  ·  Norway (6)  ·  Puerto Rico (6)

Top investigators

Joel Palefsky, MD (4)  ·  Alan Nyitray, PhD (3)  ·  Cathy Eng (3)  ·  Mark Lane Welton (3)  ·  Yongjiang Liu, Bachelor (3)  ·  Charalampos Floudas, M.D. (2)  ·  Christian S Hinrichs, MD (2)  ·  Elizabeth Stier, MD (2)  ·  Irving Salit, MD (2)  ·  Jaffer A. Ajani, MD (2)  ·  Jervoise Andreyev, MD (2)  ·  Jian Zhang, Doctor (2)  ·  Joseph A. Sparano, MD (2)  ·  Lakshmi Rajdev (2)

Results publications

PMID 23578724, PMID 28223062, PMID 18430910, PMID 20354531, PMID 20956625, PMID 28453692, PMID 31534737, PMID 32530769, PMID 8874455, PMID 12196376, PMID 12393999, PMID 15629599, PMID 17103253, PMID 18191265, PMID 18470481, PMID 19139424, PMID 19643599, PMID 19690306, PMID 19801930, PMID 20068553, PMID 20339140, PMID 20436836, PMID 20564111, PMID 20852198, PMID 21240983, PMID 21514072, PMID 22480131, PMID 23032420, PMID 23150707, PMID 23238584, PMID 23484057, PMID 23595039, PMID 24035327, PMID 24067488, PMID 25207403, PMID 25823737, PMID 26597443, PMID 27020837, PMID 27044938, PMID 27048903, PMID 27319286, PMID 27422279, PMID 27937092, PMID 28055103, PMID 28463160, PMID 28833949, PMID 28835533, PMID 29048177, PMID 29149611, PMID 29381586

NIH funding

U01CA121947 (8), UM1CA121947 (5), 2018 (4), U10CA180820 (4), 2015 (2), 2019 (2), P30CA015083 (2), P30CA016672 (2), P30CA068485 (2), K01AT008219 (1), N01CM00032 (1), N01CM00038 (1), N01CM00039 (1), N01CM00071 (1), N01CM00099 (1)